AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2013 | $3,605 | | tax credit/rebate |
IMMUNE DESIGN CORP | Merck | Washington | state | 2013 | $4,304 | | tax credit/rebate |
IMMUNE DESIGN CORP | Merck | Washington | state | 2013 | $9,868 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2013 | $13,467 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2013 | $17,655 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2013 | $19,669 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2013 | $41,681 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2013 | $44,191 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2013 | $48,418 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2013 | $62,739 | | tax credit/rebate |
SANOFI AVENTIS US LLC | Sanofi | Washington | state | 2013 | $70,422 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2013 | $102,839 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2013 | $141,588 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2013 | $298,709 | | tax credit/rebate |
Medicines Company, The | Novartis | New Jersey | state | 2013 | $1,500,000 | | grant |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2013 | $5,485,485 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Pennsylvania | state | 2013 | $5,019,493 | | tax credit/rebate |
Janssen Research & Development, LLC ( f/k/a J&J Pharmaceutical Research & Development LLC) | Johnson & Johnson | Pennsylvania | state | 2013 | $3,468,471 | | tax credit/rebate |
GlaxoSmithKline, LLC ( f/k/a SmithKline Beecham Corporation) | GlaxoSmithKline | Pennsylvania | state | 2013 | $2,357,066 | | tax credit/rebate |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2013 | $973,073 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2013 | $656,436 | | tax credit/rebate |
Auxilium Pharmacueticals, Inc. | Endo International | Pennsylvania | state | 2013 | $465,755 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | Pennsylvania | state | 2013 | $369,915 | | tax credit/rebate |
CSL Behring, LLC | CSL Limited | Pennsylvania | state | 2013 | $345,642 | | tax credit/rebate |
Immunex Corporation | Amgen | Pennsylvania | state | 2013 | $319,819 | | tax credit/rebate |
Shire US Holdings, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2013 | $255,775 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2013 | $147,484 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. (f/k/a Concurrent Pharmaceuticals, Inc.) | AbbVie | Pennsylvania | state | 2013 | $36,899 | | tax credit/rebate |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Pennsylvania | state | 2013 | $33,421 | | tax credit/rebate |
Supelco, Inc. | Merck KGaA (EMD) | Pennsylvania | state | 2013 | $25,992 | | tax credit/rebate |
Jazz Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Pennsylvania | state | 2013 | $14,203 | | tax credit/rebate |
Ventana USA | Roche | Pennsylvania | state | 2013 | $12,320 | | tax credit/rebate |
Hospira inc | Pfizer | Kansas | state | 2013 | $650,000 | | grant |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2013 | $4,414,142 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2013 | $1,077,666 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2013 | $755,362 | | tax credit/rebate |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2013 | $547,098 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2013 | $338,906 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2013 | $272,967 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2013 | $201,061 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2013 | $154,920 | | tax credit/rebate |
Pharmacia Corporation | Pfizer | North Carolina | state | 2013 | $145,378 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $115,708 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2013 | $108,155 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $85,010 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2013 | $57,596 | | tax credit/rebate |
Valeant Pharmaceuticals International | Bausch Health | North Carolina | state | 2013 | $47,287 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2013 | $42,180 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2013 | $37,544 | | tax credit/rebate |
Embrex, Inc. | Pfizer | North Carolina | state | 2013 | $31,549 | | tax credit/rebate |
Icagen, Inc. | Pfizer | North Carolina | state | 2013 | $29,917 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | North Carolina | state | 2013 | $19,136 | | tax credit/rebate |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | North Carolina | state | 2013 | $17,655 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2013 | $13,505 | | tax credit/rebate |
Pozen, Inc. | Miravo Healthcare | North Carolina | state | 2013 | $13,254 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | North Carolina | state | 2013 | $8,044 | | tax credit/rebate |
Amgen, Inc. | Amgen | North Carolina | state | 2013 | $7,359 | | tax credit/rebate |
Sprout Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2013 | $5,646 | | tax credit/rebate |
Furiex Pharmaceuticals, Inc. | AbbVie | North Carolina | state | 2013 | $4,011 | | tax credit/rebate |
Gilead Palo Alto, Inc. | Gilead Sciences | North Carolina | state | 2013 | $2,237 | | tax credit/rebate |
Amgen USA, Inc. | Amgen | North Carolina | state | 2013 | $2,120 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2013 | $1,816 | | tax credit/rebate |
Wyeth Pharmaceuticals, Inc. | Pfizer | North Carolina | state | 2013 | $1,058 | | tax credit/rebate |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2013 | $1,230,023 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $955,302 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2013 | $816,254 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2013 | $645,885 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2013 | $261,281 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2013 | $250,478 | | tax credit/rebate |
AAIPharma Services Corp. | Alcami | North Carolina | state | 2013 | $27,212 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2013 | $14,625 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2013 | $8,650 | | tax credit/rebate |
Mallinckrodt Enterprises Holdings, Inc. | Mallinckrodt | North Carolina | state | 2013 | $6,107 | | tax credit/rebate |
Novo Nordisk Pharmaceutical Industr | Novo Holdings A/S | North Carolina | state | 2013 | $65,000 | | grant |
Hospira, Inc. | Pfizer | North Carolina | state | 2013 | $483,750 | | grant |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2013 | $4,097,786 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2013 | $687,362 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2013 | $231,735 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2013 | $167,753 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $147,230 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $72,693 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2013 | $63,148 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2013 | $44,364 | | tax credit/rebate |
Eon Labs, Inc. | Novartis | North Carolina | state | 2013 | $43,359 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2013 | $29,864 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2013 | $7,529 | | tax credit/rebate |
Durata Therapeutics, Inc. | AbbVie | Connecticut | state | 2013 | $8,000 | | tax credit/rebate |
Biovail Americas Corporation and subsidiaries | Bausch Health | New Jersey | state | 2013 | $39,502,500 | | tax credit/rebate |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2013 | $2,677 | | tax credit/rebate; property tax abatement |
Forest Laboratories, Inc. | AbbVie | New York | local | 2013 | $3,462 | | tax credit/rebate; property tax abatement |
Acorda Therapeutics, Inc. | Acorda Therapeutics | New York | local | 2013 | $6,017 | | tax credit/rebate; property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2013 | $48,688 | | tax credit/rebate; property tax abatement |
Albany Molecular | Curia Inc. | New York | local | 2013 | $166,931 | | tax credit/rebate; property tax abatement |
OSI Pharmaceuticals LLC | Astellas Pharma | New York | local | 2013 | $374,233 | | tax credit/rebate; property tax abatement |
LAX/Amneal Pharmaceuticals | Amneal Pharmaceuticals | New York | local | 2013 | $393,986 | | tax credit/rebate; property tax abatement |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2013 | $426,654 | | tax credit/rebate; property tax abatement |
GLAXOSMITHKLINE & Stiefel Laboratories Inc. | GlaxoSmithKline | New York | local | 2013 | $470,487 | | tax credit/rebate; property tax abatement |
Doral/Pfizer | Pfizer | New York | local | 2013 | $516,004 | | tax credit/rebate; property tax abatement |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2013 | $1,336,023 | | tax credit/rebate; property tax abatement |
Regeneron East Greenbush | Regeneron Pharmaceuticals | New York | local | 2013 | $1,852,421 | | tax credit/rebate; property tax abatement |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2013 | $1,383,958 | | tax credit/rebate |